Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Differential Test for Flu A and B

By HospiMedica staff writers
Posted on 01 Nov 2000
A rapid in vitro assay for the direct and qualitative detection of influenza A and B viral antigens has the ability to distinguish the viral antigens of influenza A from those of influenza B, allowing for timely and proper treatment.

The assay was developed by Becton, Dickinson and Company (Sparks, MD, USA). More...
The company says it is an important advance in therapeutic decision-making for several reasons. One is that some antiviral therapies are effective only for influenza A, while others may be used to treat both strains. Thus, the assay can help clarify which treatment should be given. Second, antiviral agents must be given within the first 48 hours of illness to be effective. A test that provides results in 15 minutes promotes such treatment.

The test is an enzyme immunoassay membrane test that can be used with a variety of specimens, such as nasopharyngeal wash, nasopharyngeal aspirate, lower nasal swab, or throat swab. Easy-to-read results are determined by visual color development in the ColorPAC wells of the test device. The development of a purple triangle on the membrane in either the A or B well indicates a positive test. The test is called the BD Directigen Flu A+B.

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Digital X-Ray Detector Panel
Acuity G4
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.